Mode
Text Size
Log in / Sign up

Systematic review and meta-analysis finds pain and function improve over time in patellofemoral pain, but recovery is variableMany With Knee Pain Improve Within a Year, But Long-Term Recovery Varies

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Counsel patients that patellofemoral pain often improves over time, but recovery is variable and some have persistent symptoms.

This systematic review with meta-analysis and meta-regression assessed the long-term prognosis (>12 months) of patellofemoral pain (PFP) in adults and adolescents aged <40 years. The analysis included 3,230 participants from multiple studies. The primary outcomes were self-reported pain intensity (worst, during activity, and usual) and function.

Key findings showed reductions in worst pain (SMD 1.36, 95% CI 0.85-1.86), pain during activity (SMD 1.36, 95% CI 0.61-2.11), and resting pain (SMD 0.91, 95% CI 0.75-1.08). Function improved on the Anterior Knee Pain Scale (MD 14.60, 95% CI 11.60-17.61), FIQ (MD 3.33, 95% CI 2.46-4.20), and WOMAC (MD -7.73, 95% CI -10.36 to -5.10). However, usual pain showed no significant reduction.

The authors noted substantial heterogeneity across studies and that a considerable proportion of participants continued to report persistent symptoms. Certainty of evidence ranged from very low to moderate across outcomes. Recovery is not universal and trajectories are highly variable.

For clinicians, these findings suggest that while pain and function generally improve over time, particularly within the first 12 months, patients should be counseled that outcomes are variable and some may experience persistent symptoms.

If you have knee pain that sits behind or in front of your kneecap, you may wonder if it will ever fully go away. New research offers a clear picture of what to expect over time. It shows that many people feel better within the first year, but long-term recovery can be uneven.

This condition is called patellofemoral pain, or PFP. It is common in teens and adults under 40. It often shows up during running, climbing stairs, or sitting for long periods. Current treatments include physical therapy, activity changes, and sometimes shoe inserts. Yet many people still struggle to get lasting relief.

This review looked at long-term outcomes, not short-term fixes.

Researchers pulled together data from 42 studies that followed 3,230 patients for at least one year. Most studies focused on people under 40. They tracked pain levels and how well people could function during daily life and sports.

Here is the big shift in thinking. We used to assume that kneecap pain either gets better quickly or stays the same for years. This review shows a middle path. Pain and function often improve steadily in the first year, but after that, outcomes become much more varied.

Think of the knee as a door hinge that needs smooth alignment and steady lubrication. In PFP, the kneecap does not track perfectly in its groove. Over time, this can irritate the joint. The body tries to adapt by changing movement patterns and building tolerance. But if the load stays too high or the mechanics stay off, irritation can persist.

The research team used a method called meta-analysis. This combines results from many studies to create a more reliable estimate. They also graded the certainty of the evidence. Some findings were moderate, others were low, which means we should stay cautious about the exact numbers.

At the 12-month mark, pain during the worst moments dropped by a meaningful amount. Pain during activity also improved. Resting pain improved as well. Usual, day-to-day pain did not show the same clear change. Function scores, which measure activities like walking, squatting, and stair climbing, improved by about 14 to 15 points on common scales.

What this means in real life is that many people can do more with less sharp pain after a year. But a dull, nagging ache during everyday tasks may still be present for some.

After five years or more, the picture gets less predictable. Some people kept their gains. Others saw their improvement stall or shrink. Older age was linked to slightly better pain relief during activity at long-term follow-up, but age did not change function outcomes at one year. This suggests that time and adaptation can help some people, but not everyone.

Recovery is possible, but it is not universal.

A notable share of patients still reported symptoms long after their pain started. This highlights that PFP can be stubborn. It also shows why one-size-fits-all plans often fail. The condition likely has different drivers in different people, from muscle timing to joint shape to training loads.

An expert perspective helps frame this. The authors note that certainty of evidence ranged from very low to moderate. That means while the trends are helpful, we cannot treat every number as exact. It also underscores the need for better-designed studies that follow people for many years.

For you, this means it is reasonable to expect improvement within a year if you stick with a well-designed rehab plan. Talk with a clinician who understands PFP. Focus on building strength around the hip and knee, improving movement quality, and managing training volume. If pain lingers beyond a year, it does not mean nothing works. It may mean the plan needs to change.

This review has limits. The studies used different methods, which created wide variation. Many studies did not track every detail that could affect recovery, like prior injury history or exact training loads. And the evidence certainty was often low, which tempers how strongly we can claim specific results.

What happens next is clear. We need longer studies that start when pain begins and track people for many years. We also need studies that test tailored treatments based on what might be driving pain in each person. Until then, the best approach is steady, guided rehab with realistic expectations.

Study Details

Study typeMeta analysis
Sample sizen = 3,230
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Objective: To investigate the long-term (defined as >12 months) prognosis of knee pain and knee function in adults and adolescents with patellofemoral pain (PFP). Design: Systematic review with meta-analysis and meta-regressions. Data sources: MEDLINE, OVID, CENTRAL, Web of Science, OpenGrey, and International Patellofemoral Research Retreat abstract books. Eligibility criteria for selecting studies: Prospective studies of patients clinically diagnosed with PFP, aged <40 years, with a long-term follow-up (minimum of 12 months). Primary outcomes were self-reported pain intensity (worst, during activity, and usual) and function. Meta-analyses and meta-regressions were performed where appropriate. Narrative synthesis was performed for those not included in the metanalysis. Risk of bias was assessed using the Quality In Prognosis Studies (QUIPS) tool, and certainty of evidence using GRADE. Results: A total of 42 studies (n = 3,230) were included. At 12 months, meta-analysis indicated reduction in worst pain (SMD 1.36; 95% CI 0.85-1.86), pain during activity (SMD 1.36; 95% CI 0.61-2.11), and resting pain (SMD 0.91; 95% CI: 0.75- 1.08). No significant reduction was found for usual pain. We found improvement in self-reported function (investigated using the Anterior Knee Pain Scale (AKPS) MD 14.60; 95% CI 11.60-17.61), FIQ (MD 3.33; 95% CI: 2.46-4.20) and the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) (MD -7.73; 95% CI: -10.36 to -5.10). Extended follow-up (more than 60 months) suggested more variable improvements. Meta-regression showed no association between age and 12-month function, while older age was modestly associated with greater improvement in activity-related pain at extended follow-up. Overall, a considerable proportion of participants continued to report persistent symptoms, and heterogeneity across studies was substantial. Certainty of evidence ranged from very low to moderate across outcomes investigated. Conclusion: Pain and self-reported function generally improve over time, particularly within the first 12 months. However, substantial heterogeneity and persistent symptoms in a considerable proportion of patients at extended follow-up indicate that recovery is not universal and trajectories are highly variable.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.